FDA Approves Cefepime for Use in B. Braun’s Duplex System

The U.S. Food and Drug Administration has approved an application that permits B. Braun Medical to deliver FDA-approved 1-g and 2-g cefepime for Injection USP and Dextrose Injection USP in B. Braun’s DUPLEX Drug Delivery System, according to a B. Braun news release.

Advertisement

Cefepime is used to treat a wide variety of bacterial infections, and the availability of 1-g and 2-g cefepime in the DUPLEX System will allow more accurate administration of cefepime to patients as it can be stored ready-to-use in a container, according to the release.  

The DUPLEX Drug Delivery System is a ready-to-use, two-compartment, flexible IV container that stores pre-measured pharmaceuticals and diluent doses. Healthcare workers administering 1-g or 2g cefepime through DUPLEX simply fold and squeeze the container and shake it to mix the pharmaceuticals and diluent.

Learn more about B. Braun.

Advertisement

Next Up in Pharmacy

  • CMS published plans Dec. 23 for its voluntary “Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth” — or BALANCE…

Advertisement

Comments are closed.